SCHEMBL30340909

SCHEMBL30340909

Fc1ccc(-c2ccc3nc(N4CCCCC4)ccc3c2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 4/20 0.58
▸ RXFP1 Q9HBX9 3/20 0.55
▸ PIM1 P11309 2/20 0.51
▸ HDAC3 O15379 1/20 0.48
▸ HDAC2 Q92769 1/20 0.48
▸ HRH3 Q9Y5N1 2/20 0.47
▸ HSD17B10 Q99714 1/20 0.44
▸ HTR3A P46098 1/20 0.43
▸ HRH4 Q9H3N8 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25488432 0.88 RXFP1 (0.56) MAOBRXFP1PIM1HRH3HTR3A
SCHEMBL30771683 0.87 MAOB (0.62) MAOBRXFP1PIM1NPC1RAB9A
SCHEMBL30771693 0.85 PIM1 (0.51) MAOBRXFP1PIM1HRH3HTR3A
SCHEMBL30340907 0.85 CSNK1D (0.50) MAOBRXFP1HRH3HTR3AHRH4
SCHEMBL30771674 0.85 HRH3 (0.56) MAOBRXFP1HRH3HTR3AHRH4
SCHEMBL30771676 0.83 MAOB (0.44) MAOBRXFP1HRH3HTR3AHRH4
SCHEMBL30771687 0.83 PDE10A (0.48) MAOBRXFP1HRH3HTR3AHRH4
SCHEMBL30340903 0.82 MAOB (0.60) MAOBPIM1HDAC2HRH3HSD17B10
SCHEMBL30771667 0.81 PDE10A (0.46) MAOBPIM1HRH3TP53
SCHEMBL30771669 0.81 HTR3A (0.43) MAOBRXFP1HRH3HTR3AHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081304-B1 ANTIBACTERIAL QUINOLINES TECNIMEDE SOCIEDADE TECNICO MEDICINAL SA (PT) 2024-03-06 — — EP claimed
US-12383548-B2 Antibacterial quinolines Tecnimede—Sociedade Técnico-Medicinal, SA (PT) 2025-08-12 — — US disclosed
US-20230106913-A1 Antibacterial quinolines TECNIMEDE - Sociedade Técnico-medicinal, SA (PT) 2023-04-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12383548-B2 Antibacterial quinolines NQO2, RABGGTB, NQO1 MAOB 1608/4885RXFP1 3805/4885PIM1 2565/4885
US-20230106913-A1 Antibacterial quinolines NQO2, RABGGTB, NQO1 MAOB 1608/4885RXFP1 3805/4885PIM1 2565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback